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m.3243A>Ga b s t r a c t
Background: Type II diabetes is the most often considered as maternally inherited disease and A>G tran-
sition at position 3243 of mitochondrial DNA (m.3243A>G) in the encoding tRNALeu (UUR) gene is thought
to be strongly responsible for the pathogenesis of the disease in number of cases.
Aim: Current study was conducted to investigate the family prevalence of m.3243A>G mutation in a
Pakistani family with the context of insulin sensitivity and B-cell function.
Subject and method
This study was carried out in 6 suspected diabetic members of a Pakistani family. Mitochondrial DNA was
extracted from saliva and after polymerase chain reaction, amplified DNA was subjected to direct
sequencing.
Results and conclusion: Sequencing results revealed absence of most common mtDNA m.3243A>G muta-
tion in 6 subjects with devotedly congenital mitochondrial diabetes phenotype. Conclusively, the
m.3243A>G mutation in mitochondrial tRNALeu gene was not found to be a frequent cause of Type II dia-
betes mellitus in a Pakistani (haripur) family. Our finding suggests that there might be some underlying
genetic cause for Type II diabetes mellitus in the subjects under study.
 2016 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetes is multifactorial disorder characterized by inappropri-
ate secretion of insulin leading to chronic hyperglycemia. Pancre-
atic B-cells are key player in maintaining normal glucose
homeostasis by secretion of insulin. There are number of genetic
and non-genetic risk factors associated with diabetes. Generally
mitochondrial diabetes is an unremarkable form of diabetes with
familial clustering. Type II diabetes has maternal inheritance pat-
tern and in majority of the cases m.3243A>G heteroplasmic muta-
tion encoding tRNALeu (UUR) gene is thought to be responsible for
the disease phenotype [1,2].Underlying molecular mechanism include gradual B-cell failure
beside impaired insulin sensitivity [3]. In m.3243A>G mutant
individual there is impaired insulin secretory capacity of pancre-
atic B-cell due to impaired glucose sensing mechanism [4]. Clinical
manifestation of m.3243A>G point mutation in Type II maternally
inherited diabetes also include, obesity, hearing and visual impair-
ment, renal dysfunction, maternal inheritance and association with
progressive neurosensorial deafness. This mutation is also reported
in association with the MELAS syndrome (encephalomyopathy,
lactic acidosis, and stroke-like episodes syndrome) [5–9].
The m.3243A>G mutation leads to the dimerization of the
mutant tRNA molecule and impaired amino acylation [10]. The
precise consequences for biochemical processes within the mito-
chondrion are a matter of debate but seem to encompass distorted
mitochondrial proteome. Furthermore, high heteroplasmy levels
lead to mitigated oxygen consumption, depicting functional
impairment of the respiratory chain [7]. Five different point muta-
tions i.e. m.3156A>G, m.3243A>G, m.3357G>A, m.3375C>A, and
m.3394T>C were reported among 240 diabetic subjects in Japanes
population [11]. Apart from these some other mitochondrial point
Fig. 2. (A) Agarose gel electrophoresis photograph of isolated DNA. (B) Agarose gel
electrophoresis photograph of PCR amplified DNA fragments.
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m.3252A>G, m.3260A>G, m.3265C>T, m.1888G>A, m.4216T>G
andm.4917A>G. Mitochondrial mutations m.3357G>A (Met? Ile)
and m.3394T>C (Tyr? His) showed strong association with Type
II diabetes [9]. Conclusively the previous data revealed that
m.3243A>G is primary cause of maternally inherited Type II dia-
betes in approximately 1.5% of diabetic individuals from Japan’s
and the Netherlands population [12]. Given the enormous chal-
lenge of diabetes mellitus epidemic in the coming years on one
hand and the lack of resources on the other, it is mandatory to ini-
tiate proactive measure on urgent basis [13]. In the present study
we sought to determine whether this m. 3243A>G variant is signif-
icantly associated with proven Type II diabetes in a Pakistani
family.
2. Subjects and methods
2.1. Subjects
Prior to the start of the study, approval was obtained from the
Hazara University Institutional Review Board and written informed
consent was obtained from all the 6 patients (2 female and 4 male)
and control individuals of the same family.
2.2. Samples collection
All patients underwent a standardized clinical and laboratory
evaluation. Next, samples were collected from the 6 suspected dia-
betic members of the same family (Fig. 1). We collected 1.5–2.0 mL
of saliva from each participant to extract adequate amount of DNA.
Each sample was held on ice and freeze at 20 as soon as possible.
2.3. DNA extraction, Library preparation and sequencing
Genomic DNA was isolated from saliva following a standard
protocol, quantified by spectrophotometric measurement of opti-
cal density at 260 nm and diluted to 40 ng/mL for amplification
by polymerase chain reaction (PCR). To screen for mutations, all
coding exons and exon/ intron splice junctions of the MT-TL1 gene
were PCR amplified from genomic DNA using primers designed
from intronic sequences of the gene (Fig. 2). To amplify the PCR
fragment containing tRNALEU gene, the following primers were
used: 50-TCCAATAACTTGACCAACGGAACAAG-30 (forward), 50-AACFig. 1. Pedigree of patients with Type II maternally inherited diabetes mellitus.
Affected members are shown by filled symbols. Numbers are given for family
members who provided the sample and informed consent for the study. In the
pedigree each proband is indicated by asterisk.GTTGTGGTCTTTGCGTAGTTGTA-30 (reverse). The PCR products
were purified using the Gene JETTM PCR purification kit (#
K0701) and were sent for sequencing to Macrogen Korea
(www.macrogen.com). Sequence variants were identified using
Bioedit; a sequence alignment editor version 6.0.7 (http://www.
mbio.ncsu.edu/bioedit/bioedit).
3. Results and discussion
3.1. Clinical finding
All the probands of the family were underwent clinical and lab-
oratory examination. Probands with Type II diabetes of maternal
history showed some shared clinical characteristics e.g. dry mouth,
weight loss and muscular pain (Table 1).
3.2. Mutation analysis of MT-TL1 gene
The tRNALeu(UUR) gene in 6 probands of the family were
sequenced as well as their flanking regions. After thorough
sequence analysis of the probands we were unable to identify
homozygous A>G transition at nucleotide position 3243 located
in the tRNALEU gene. Bidirectional DNA sequencing further vali-
dated our sequencing results. Next, we performed comparative
analysis of the patient’s sequences with the standard sequences
obtained from NCBI (https://www.ncbi.nlm.nih.gov). Comparison
of diabetic individuals with control (Fig. 3) further validated the
sequencing data.
Mutations of mtDNA, particularly in tRNALEU gene are emerging
surprisingly as a major cause of maternally inherited Type II
diabetes mellitus in developed countries. The prevalence of mtDNA
MT-TL1 gene mutations in the Pakistani family is yet to be
explored. In the present study, we selected a family with 6
probands having maternally inherited Type II diabetes mellitus
Table 1
Sampling details of diabetic individuals with maternal history.
Tube No. Names Age Family history Duration of disease Symptoms Medicines
D13 ZahidaBibi 65 Mother 14 Years Thirst, Pain in foots, Frequent Urination Minidiab.
D21 AteeqAslam 48 Son, Brother 7 Years Dry Mouth, Weight loss Glucophage
D23 ShaheenaBibi 47 Daughter, Sister 6 Years Frequent Urination, Hunger Getformin
D24 Parvez Iqbal 45 Son, Brother 4 Years Dry Mouth, Weight loss Neodopar
D25 Ali Asghar 43 Son, Brother 2 Years Muscular Pain Daomil
D27 TanveerIqbal 40 Sister husband 1 Year Dry Mouth, Weight loss Insulin
Fig. 3. Sequencing peaks of six patients: (a) D13, Sequence peak of tRNA(LEU)gene from 307 to 381 (b) D21, Sequence peak of tRNA(LEU)gene from 310 to 384 (c) D23, Sequence
peak of tRNA(LEU)gene from 311 to 385 (d) D27 Sequence peak of tRNA(LEU)gene from 302 to 376 (e) D25, Sequence peak of tRNA(LEU)gene from 301 to 375 (f) D24, Sequence
peak of tRNA(LEU)gene from 303 to 377.
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ant of MT-TL1 gene in a Pakistani family. Parallel researches con-
ducted in Argentina [14], Poland [15] and Indonesia [16] were
found unproductive in discerning an m. 3243A>G mutation. Thus
our findings in a Pakistani family further strengthen the previous
studies in context of m. 3243A>G variant.
Conclusively, although previous clinical observations and stud-
ies have suggested some role of mitochondrial dysfunctions in the
progression of Type II diabetes mellitus but the mutations in mito-
chondrial MT-TL1 gene cannot be labeled as a major contributing
etiological factor of Type II diabetes mellitus in a Pakistani family.
But we cannot exclude the significance of other genetic variants in
the etiology of maternally inherited diabetes. Mitochondrial gen-
ome is susceptible to pathogenic mutations, hence comprehensive
and thorough detection of mitochondrial DNA mutations requires
sequencing of the entire mtDNA for investigation of underlying
molecular and genetic factors.Conflict of interest
Authors declare no conflict of interest.References
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